Man Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.64M Buy
8,109
+1,038
+15% +$338K 0.01% 1117
2025
Q1
$1.91M Sell
7,071
-9,311
-57% -$2.51M ﹤0.01% 1195
2024
Q4
$3.85M Sell
16,382
-93,421
-85% -$22M 0.01% 978
2024
Q3
$30.2M Sell
109,803
-8,107
-7% -$2.23M 0.08% 293
2024
Q2
$28.7M Sell
117,910
-92,325
-44% -$22.4M 0.07% 302
2024
Q1
$31.4M Buy
210,235
+167,345
+390% +$25M 0.08% 275
2023
Q4
$8.21M Buy
+42,890
New +$8.21M 0.02% 712
2023
Q3
Sell
-50,679
Closed -$9.63M 980
2023
Q2
$9.63M Buy
+50,679
New +$9.63M 0.03% 632
2023
Q1
Sell
-1,841
Closed -$438K 265
2022
Q4
$438K Buy
1,841
+523
+40% +$124K ﹤0.01% 1542
2022
Q3
$264K Buy
+1,318
New +$264K ﹤0.01% 1667
2022
Q2
Sell
-1,374
Closed -$224K 555
2022
Q1
$224K Buy
+1,374
New +$224K ﹤0.01% 1836
2021
Q4
Sell
-3,443
Closed -$650K 1864
2021
Q3
$650K Buy
+3,443
New +$650K ﹤0.01% 1460
2021
Q1
Sell
-19,992
Closed -$2.6M 1832
2020
Q4
$2.6M Sell
19,992
-1,921
-9% -$250K 0.01% 1103
2020
Q3
$3.19M Sell
21,913
-36,971
-63% -$5.38M 0.01% 1022
2020
Q2
$8.72M Buy
58,884
+56,184
+2,081% +$8.32M 0.04% 410
2020
Q1
$294K Sell
2,700
-515
-16% -$56.1K ﹤0.01% 1378
2019
Q4
$370K Sell
3,215
-8,255
-72% -$950K ﹤0.01% 1636
2019
Q3
$923K Sell
11,470
-25,482
-69% -$2.05M ﹤0.01% 1447
2019
Q2
$2.68M Buy
36,952
+16,890
+84% +$1.23M 0.01% 1204
2019
Q1
$1.88M Sell
20,062
-2,017
-9% -$189K 0.01% 1352
2018
Q4
$1.61M Sell
22,079
-3,281
-13% -$239K 0.01% 1288
2018
Q3
$2.22M Sell
25,360
-9,810
-28% -$859K 0.01% 1364
2018
Q2
$3.46M Buy
35,170
+32,770
+1,365% +$3.23M 0.01% 1108
2018
Q1
$286K Buy
+2,400
New +$286K ﹤0.01% 1832